OUR LOCATION

322-Washington,America - 23

(+1)123 456 789

Emergency Call- 24/7 support

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Healthcare IT » HHE-3301016
  • Global Healthcare BPO Market-Technologies, Market share and Industry Forecast to 2024

  • Publish: October 2016 | Report Code: HHE-3301016

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Business process outsourcing is a process of contracting of non-primary business activities such as human resources (HR), payroll, accounting, etc. to a third-party vendor or service provider in order to provide expert knowledge in the required field. The global healthcare BPO market is estimated to grow with a CAGR of 11.4% during the forecast period of 2016-2023. The key trend affecting the global healthcare BPO market is the advancement of technology. Through the technological innovation such as cloud computing, business analytics software, social media platforms etc the BPO can offer better technology to support in optimizingthe revenue cycle which may be costly and time consuming. The innovations can enhance customer service, receivables and data security .The global healthcare BPO market is primarily driven by following factors:

  • Pressure to reduce increasing healthcare costs
  • Complex clinical trial protocols
  • Enactment of PPACA (Patient Protection and Affordable Care Act)
  • Patent expiry of blockbuster drugs
  • Increasing trend of medical document outsourcing






The key factor contributing to the growth of global healthcare BPO market is the pressure to reduce healthcare expenditure which will lead to the rise in the demand of business process outsourcing in healthcare sector. The BPO aids various policymakers to reduce the current level of healthcare expenditure without creating unnecessary burdens for providers. However, the fear of losing control over the business process and hidden costs of outsourcing are the major factors restraining the growth of global healthcare BPO market. Sometimes outsourcing prices are downright hidden or less visible. The major hidden costs in the outsourcing are currency, software or hardware refresh, lack of governance, retained organization, internal transition, poor change communications, retirement costs, planned headcount reduction, staff augmentation and shadow organizations. Some of the key opportunities of healthcare BPO market are mandatory implementation of ICD (the International Statistical Classification of Diseases and Related Health Problems)-10 Codes in and consolidation of the healthcare system developed regions. ICD – 10 (the International Statistical Classification of Diseases and Related Health Problems), introduced by World Health Organization (WHO) is the set of codes of over 14,500 different codes of symptoms and signs, complaints, external causes of diseases or injury, social circumstances, and various other diseases; and, also allows tracking of new diagnosis.

Source: OBRC Analysis

The global healthcare BPO market is segmented into provider service, payer service, and pharmaceutical service. The provider service of global healthcare BPO market is further sub segmented into:

  • Medical billing
  • Medical coding
  • Medical transcription
  • Finance & accounts





Payer service is further segmented into:

  • Front-end services and back-office operations
  • Claims management services
  • Member management services
  • Provider management services
  • Billing and accounts management services
  • Analytics and fraud management services
  • HR services








  Pharmaceutical service is further segmented into:

  • Research & Development
  • Manufacturing
  • Non-clinical services
  • Other non-clinical services





The revenue for the above services are specific to the healthcare BPO market. However, the total revenue of these services in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up provider, payer and the pharmaceutical services segment.

Geographically, the global healthcare BPO market is segmented into:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America is expected to hold the largest market share during the forecast period 2016-2023 followed by Europe. In North America, U.S. is the major source for the outsourcing of healthcare services owing to enactment of PPACA (Patient Protection and Affordable Care Act) and implementation of ICD-10 codes. After North America, Europe is the biggest source for outsourcing healthcare services due to minimum healthcare delivery prices. In Asia-Pacific, China and India are the most ideal locations for outsourcing from due to availability of adept personnel and has less operating business costs.

The global healthcare BPO market is segmented on the basis of provider service, payer service, and pharmaceutical service. By provider service, the global healthcare BPO market is further segmented into medical billing, medical coding, medical transcription, and finance & accounts. Medical billing had the largest market share in 2016. Based on the payer service, the market is segmented into claims management services, integrated front-end services and back-office operations, member management services, provider management services, billing and accounts management services, analytics and fraud management services, and HR services. Claims management services is further segmented into claims adjudication services, claims settlement, information management services, claims repricing, claims investigation services, claims indexing services, and litigation management. Based on the pharmaceutical service, the market is segmented into research & development, manufacturing, and non-clinical services. The non-clinical services are further segmented into supply chain management & logistics, sales and marketing services, and other non-clinical functions. Sales and marketing services are also further segmented into sales and marketing services, performance reporting, analytics, research, and marketing services.

The major market players of the global healthcare BPO market are:

  • ACCRETIVE HEALTH, INC.,
  • ACCENTURE
  • IBM CORPORATION
  • INFOSYS BPO LIMITED
  • QUINTILES TRANSNATIONAL HOLDINGS
  • OTHERS







These companies use various strategies such as mergers & acquisition, collaboration, partnership and product launching. Example: In March 2016, Quintles Transnational Holding got merged with the IMS health. The merger created one of the largest portfolios for deep therapeutic domain, healthcare information, regulatory and commercial analytical expertise and proprietary technology application with more than 50000 employees operating in more than 100 countries. The IMS-Quintles merger became a global real world evidence solutions platform through joining a leading portfolio of technology enabled data collection, patient’s records and observational research experts to discourse important healthcare issues such as value, cost and patient outcomes.

Detailed analysis of these companies provided in this report comprises of overview, scot analysis, product portfolio, strategic initiative and strategic analysis.

Why to buy the report:

This report will:

  • Provide you the business strategies adopted by market player such as merger as on March 2016 IMS health merged with Quintles Transnational Holdings.
  • Provide in detail the different segments such as provider service, payer service and pharmaceutical service which affect the global healthcare BPO market.
  • Provide you the patent analysis of global healthcare BPO market.
  • Identify and understand the strengths, opportunities, challenges and threat of the global healthcare BPO market.
  • Provide revenues of major players of the market such as Cognizant Technology Solutions Corporation, Accretive Health, Inc.
  • Provide you the various regulatory policies which affect the global healthcare BPO market.







How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global healthcare BPO offers the longest chain of market segmentation covering major market segmentation based on products and end users.The report tracks the major market trends in the global healthcare BPO market such as technological innovations which leads to more value added services. For each market segments covered in global healthcare BPO market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the healthcare BPO industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data. 

Key findings of the global healthcare BPO market:

  • North America had the largest revenue share in 2016.
  • Claims management segment is dominating the market due to validation of PPACA and high pressure to make healthcare more affordable.
  • Merger and partnership are the key strategies adopted by various market players of global healthcare BPO market.
  • Manufacturing segment is the major segment of pharmaceutical services segment

1.       INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2.       MARKET OVERVIEW

2.1. GLOBAL HEALTCARE BPO MARKET : EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. TOTAL MARKET ANALYSIS

2.4.1.        TOP 5 FINDINGS

2.4.2.        TOP 5 OPPORTUNITY MARKETS

2.4.3.        TOP 5 COMPANIES

2.4.4.        TOP 3 COMPETITIVE STRATEGIES

2.5. ESTIMATION ANALYSIS

2.6. STRATEGIC ANALYSIS

2.6.1.        INVESTMENT VS. ADOPTION MODEL

2.6.2.        360-DEGREE INDUSTRY ANALYSIS

2.6.3.        PORTERS 5 FORCE MODEL

2.6.4.        SEE-SAW ANALYSIS

2.6.5.        CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.7. COMPETITIVE ANALYSIS

2.7.1.        KEY STRATEGIES & ANALYSIS

2.7.2.        MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS

2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.8.1.        INVESTMENT OPPORTUNITIES BY REGIONS

2.8.2.        OPPORTUNITIES IN EMERGING APPLICATIONS

2.8.3.        INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3.       MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1.        PRESSURE TO REDUCE INCREASING HEALTHCARE COSTS

3.1.2.         COMPLEX CLINICAL TRIAL PROTOCOLS

3.1.3.        ENACTMENT OF PPACA

3.1.4.        STRINGENT REGULATORY REQUIREMENTS

3.1.5.        PATENT EXPIRY OF DRUGS

3.1.6.         INCREASING  TREND OF MEDICAL DOCUMENT OUTSOURCING

3.2. MARKET RESTRAINTS

3.2.1.        FEAR OF LOSING CONTROL OVER THE BUSINESS PROCESS

3.2.2.         HIDDEN EXPENDITURE OF OUTSOURCING

3.3. MARKET OPPORTUNITIES

3.3.1.        MANDATORY IMPLEMENTATION OF ICD-10 CODES

3.3.2.         CONSOLIDATION OF THE HEALTHCARE SYSTEM

3.4.   MARKET CHALLENGES

3.4.1.        PRODUCT QUALITY LOSS

3.4.2.         LACK OF ADEQUATE INFRASTRUCTURE FOR PRE-CLINICAL LEARNING

3.4.3.        DATA SECURITY AND PRIVACY

4.      GLOBAL HEALTHCARE BPO  MARKET BY PROVIDE SOURCE

4.1. MARKET DEFINITION AND SCOPE

4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4.  OPPORTUNITY MATRIX

4.5. MARKET SEGMENTATION

4.5.1.      GLOBAL MEDICAL BILLING PROVIDE SOURCE  MARKET

4.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3.  MARKET PARTICIPANTS AND PRODUCTS

4.5.1.4.  KEY CONCLUSIONS

4.5.2.      GLOBAL MEDICAL CODING PROVIDER SOURCE  MARKET

4.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3.  MARKET PARTICIPANTS AND PRODUCTS

4.5.2.4.  KEY CONCLUSIONS

4.5.3.      GLOBAL MEDICAL TRANSCRIPTION PROVIDER SOURCE  MARKET

4.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.3.3.  MARKET PARTICIPANTS AND PRODUCTS

4.5.3.4.  KEY CONCLUSIONS

4.5.3.5.                        GLOBAL FINANCE & ACCOUNTS MARKET

4.5.3.6.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.3.7.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.3.8.  MARKET PARTICIPANTS AND PRODUCTS

4.5.3.9.  KEY CONCLUSIONS

5.      GLOBAL HEALTHCARE BPO  MARKET BY PAYER SERVICE

5.1. MARKET DEFINITION AND SCOPE

5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

5.4.  OPPORTUNITY MATRIX

5.5. MARKET SEGMENTATION

5.5.1.1.  GLOBAL INTEGRATED FRONT-END SERVICES AND BACK-OFFICE OPERATIONS PAYER SERVICE MARKET  

5.5.1.2.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.1.3.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.1.4.  MARKET PARTICIPANTS AND PRODUCTS

5.5.1.5.  KEY CONCLUSIONS

5.5.2.      GLOBAL CLAIMS MANAGEMENT SERVICES PAYER SERVICE MARKET

5.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.2.3.  MARKET PARTICIPANTS AND PRODUCTS

5.5.2.4.  KEY CONCLUSIONS

5.5.3.      GLOBAL MEMBER MANAGEMENT SERVICES PAYER SERVICE MARKET

5.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.3.3.  MARKET PARTICIPANTS AND PRODUCTS

5.5.3.4.  KEY CONCLUSIONS

5.5.4.      GLOBAL HEALTHCARE BPO BY PROVIDER MANAGEMENT SERVICES PAYER SERVICE MARKET

5.5.4.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.4.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.4.3.  MARKET PARTICIPANTS AND PRODUCTS

5.5.4.4.  KEY CONCLUSIONS

5.5.5.      GLOBAL BILLING AND ACCOUNTS MANAGEMENT SERVICES PAYER SERVICE MARKET

5.5.5.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.5.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.5.3.  MARKET PARTICIPANTS AND PRODUCTS

5.5.5.4.  KEY CONCLUSIONS

5.5.6.      GLOBAL ANALYTICS AND FRAUD MANAGEMENT SERVICES PAYER SERVICE  MARKET

5.5.6.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.6.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.6.3.  MARKET PARTICIPANTS AND PRODUCTS

5.5.6.4.  KEY CONCLUSIONS

5.5.6.5.                        GLOBAL HEALTHCARE BPO BY HR SERVICES PAYER SERVICE MARKET

5.5.6.6.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.6.7.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.6.8.  MARKET PARTICIPANTS AND PRODUCTS

5.5.6.9.  KEY CONCLUSIONS

5.5.6.10.                    GLOBAL HEALTHCARE BPO MARKET BY PHARMACEUTICAL SERVICE MARKET

5.5.6.11.                      ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.6.12.                      MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.6.13.                      MARKET PARTICIPANTS AND PRODUCTS

5.5.6.14.                      KEY CONCLUSIONS

6.      GLOBAL HEALTHCARE BPO MARKET BY PHARMACEUTICAL SERVICE MARKET

6.1. MARKET DEFINITION AND SCOPE

6.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.4.  OPPORTUNITY MATRIX

6.5. MARKET SEGMENTATION

6.5.1.        GLOBAL LOBAL RESEARCH & DEVELOPMENT PHARMACEUTICAL SERVICE  MARKET

6.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.1.3.  MARKET PARTICIPANTS AND PRODUCTS

6.5.1.4.  KEY CONCLUSIONS

6.5.2.      GLOBAL MANUFACTURING MARKET PHARMACEUTICAL SERVICE MARKET

6.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.2.3.  MARKET PARTICIPANTS AND PRODUCTS

6.5.2.4.  KEY CONCLUSIONS

6.5.3.      GLOBAL BY NON-CLINICAL SERVICES PHARMACEUTICAL SERVICE MARKET

6.5.3.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.3.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.3.3.  MARKET PARTICIPANTS AND PRODUCTS

6.5.3.4.  KEY CONCLUSIONS

6.5.4.      GLOBAL OTHER NON-CLINICAL FUNCTIONS PHARMACEUTICAL SERVICE MARKET

6.5.4.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.4.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.4.3.  MARKET PARTICIPANTS AND PRODUCTS

6.5.4.4.  KEY CONCLUSIONS

7.       COMPETITIVE LANDSCAPE

7.1. KEY STRATEGIES

7.1.1.        LIST OF MERGERS AND ACQUISITION

7.1.2.        LIST OF JOINT VENTURES

7.1.3.        LIST OF PRODUCT LAUNCHES

7.1.4.        LIST OF PARTNERSHIPS

8.       GEOGRAPHIC ANALYSIS

8.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

8.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

8.3. OPPORTUNITY MATRIX

8.4.                      GLOBAL HEALTHCARE BPO  MARKET BY REGION 2015-2024  

8.4.1.      NORTH AMERICA

8.4.1.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

8.4.1.2.  TOP COUNTRY ANALYSIS

8.4.1.2.1.      U.S.

8.4.1.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.4.1.2.1.2.   MARKET PARTICIPANTS AND PRODUCTS

8.4.1.2.1.3.   KEY CONCLUSIONS

8.4.1.2.2.      CANADA

8.4.1.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.4.1.2.2.2.   MARKET PARTICIPANTS AND PRODUCTS

8.4.1.2.2.3.   KEY CONCLUSIONS

8.4.2.      EUROPE

8.4.2.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

8.4.2.2.  TOP COUNTRY ANALYSIS

8.4.2.2.1.      UK

8.4.2.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.4.2.2.1.2.   MARKET PARTICIPANTS AND PRODUCTS

8.4.2.2.1.3.   KEY CONCLUSIONS

8.4.2.2.2.      FRANCE

8.4.2.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.4.2.2.2.2.   MARKET PARTICIPANTS AND PRODUCTS

8.4.2.2.2.3.   KEY CONCLUSIONS

8.4.2.2.3.      GERMANY

8.4.2.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.4.2.2.3.2.   MARKET PARTICIPANTS AND PRODUCTS

8.4.2.2.3.3.   KEY CONCLUSIONS

8.4.2.2.4.      SPAIN

8.4.2.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.4.2.2.4.2.   MARKET PARTICIPANTS AND PRODUCTS

8.4.2.2.4.3.   KEY CONCLUSIONS

8.4.2.2.5.      REST OF EUROPE

8.4.2.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.4.2.2.5.2.   KEY  PLAYERS & KEY PRODUCTS

8.4.2.2.5.3.   KEY CONCLUSIONS

8.4.3.      ASIA PACIFIC

8.4.3.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

8.4.3.2.  TOP COUNTRY ANALYSIS

8.4.3.2.1.      CHINA

8.4.3.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.4.3.2.1.2.   MARKET PARTICIPANTS AND PRODUCTS

8.4.3.2.1.3.   KEY CONCLUSIONS

8.4.3.2.2.      INDIA

8.4.3.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.4.3.2.2.2.   MARKET PARTICIPANTS AND PRODUCTS

8.4.3.2.2.3.   KEY CONCLUSIONS

8.4.3.2.3.      JAPAN

8.4.3.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.4.3.2.3.2.   MARKET PARTICIPANTS AND PRODUCTS

8.4.3.2.3.3.   KEY CONCLUSIONS

8.4.3.2.4.      AUSTRALIA

8.4.3.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.4.3.2.4.2.   KEY  PLAYERS & KEY PRODUCTS

8.4.3.2.4.3.   KEY CONCLUSIONS

8.4.3.2.5.      REST OF ASIA PACIFIC

8.4.3.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.4.3.2.5.2.   KEY  PLAYERS & KEY PRODUCTS

8.4.3.2.5.3.   KEY CONCLUSIONS

8.4.4.      ROW

8.4.4.1.  INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

8.4.4.2.  TOP COUNTRY ANALYSIS

8.4.4.2.1.      LATIN AMERICA

8.4.4.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.4.4.2.1.2.   MARKET PARTICIPANTS AND PRODUCTS

8.4.4.2.1.3.   KEY CONCLUSIONS

8.4.4.2.2.      MIDDLE EAST & AFRICA

8.4.4.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.4.4.2.2.2.   MARKET PARTICIPANTS AND PRODUCTS

8.4.4.2.2.3.   KEY CONCLUSIONS

9.       COMPANY PROFILES

9.1.1.        ACCENTURE PLC  (IRELAND)

9.1.2.        OVERVIEW

9.1.3.        PRODUCT PORTFOLIO

9.1.4.        STRATEGIC INITIATIVES

9.1.5.        SCOT ANALYSIS

9.1.6.        STRATEGIC ANALYSIS

9.2.   ACCRETIVE HEALTH, INC.(U.S)

9.2.1.        OVERVIEW

9.2.2.        PRODUCT PORTFOLIO

9.2.3.        STRATEGIC INITIATIVES

9.2.4.        SCOT ANALYSIS

9.2.5.        STRATEGIC ANALYSIS

9.3. BOEHRINGER INGELHEIM (US)

9.3.1.        OVERVIEW

9.3.2.        PRODUCT PORTFOLIO

9.3.3.        STRATEGIC INITIATIVES

9.3.4.        SCOT ANALYSIS

9.3.5.        STRATEGIC ANALYSIS

9.4. CATALENT

9.4.1.        OVERVIEW

9.4.2.        PRODUCT PORTFOLIO

9.4.3.        STRATEGIC INITIATIVES

9.4.4.        SCOT ANALYSIS

9.4.5.        STRATEGIC ANALYSIS

9.5. COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION

9.5.1.        OVERVIEW

9.5.2.        PRODUCT PORTFOLIO

9.5.3.        STRATEGIC INITIATIVES

9.5.4.        SCOT ANALYSIS

9.5.5.        STRATEGIC ANALYSIS

9.6. DSM PHARMA (DSM) (NETHERLAND)

9.6.1.        OVERVIEW

9.6.2.        PRODUCT PORTFOLIO

9.6.3.        STRATEGIC INITIATIVES

9.6.4.        SCOT ANALYSIS

9.6.5.        STRATEGIC ANALYSIS

9.7. GEBBS HEALTHCARE (US)

9.7.1.        OVERVIEW

9.7.2.        PRODUCT PORTFOLIO

9.7.3.        STRATEGIC INITIATIVES

9.7.4.        SCOT ANALYSIS

9.7.5.        STRATEGIC ANALYSIS

9.8. GENPACT LIMITED

9.8.1.        OVERVIEW

9.8.2.        PRODUCT PORTFOLIO

9.8.3.        STRATEGIC INITIATIVES

9.8.4.        SCOT ANALYSIS

9.8.5.        STRATEGIC ANALYSIS

9.9. IBM CORPORATION (U.S.)

9.9.1.        OVERVIEW

9.9.2.        PRODUCT PORTFOLIO

9.9.3.        STRATEGIC INITIATIVES

9.9.4.        SCOT ANALYSIS

9.9.5.        STRATEGIC ANALYSIS

9.10.                  INFOSYS BPO LIMITED (US)

9.10.1.   OVERVIEW

9.10.2.   PRODUCT PORTFOLIO

9.10.3.   STRATEGIC INITIATIVES

9.10.4.   SCOT ANALYSIS

9.10.5.   STRATEGIC ANALYSIS

9.11.                  LONZA GROUP LTD.(SWITZERLAND)

9.11.1.   OVERVIEW

9.11.2.   PRODUCT PORTFOLIO

9.11.3.   STRATEGIC INITIATIVES

9.11.4.   SCOT ANALYSIS

9.11.5.   STRATEGIC ANALYSIS

9.12.                  MEDUSIND

9.12.1.   OVERVIEW

9.12.2.   PRODUCT PORTFOLIO

9.12.3.   STRATEGIC INITIATIVES

9.12.4.   SCOT ANALYSIS

9.12.5.   STRATEGIC ANALYSIS

9.13.                  QUINTILES TRANSNATIONAL HOLDINGS, INC.

9.13.1.   OVERVIEW 

9.13.2.   PRODUCT PORTFOLIO

9.13.3.   STRATEGIC INITIATIVES

9.13.4.   SCOT ANALYSIS

9.13.5.   STRATEGIC ANALYSIS

9.14.                  TATA CONSULTANCY SERVICES LTD.(INDIA)

9.14.1.   OVERVIEW

9.14.2.   PRODUCT PORTFOLIO

9.14.3.   STRATEGIC INITIATIVES

9.14.4.   SCOT ANALYSIS

9.14.5.   STRATEGIC ANALYSIS

9.15.                  XEROX CORPORATION(US)

9.15.1.   OVERVIEW

9.15.2.   PRODUCT PORTFOLIO

9.15.3.   STRATEGIC INITIATIVES

9.15.4.   SCOT ANALYSIS

9.15.5.   STRATEGIC ANALYSIS

LIST OF TABLES

1.       GLOBAL HEALTHCARE BPO  MARKET BY PROVIDE SOURCE  2015-2024 ($ MILLION)

2.       GLOBAL MEDICAL BILLING MARKET PROVIDE SOURCE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL MEDICAL CODING PROVIDE SOURCE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

4.       GLOBAL MEDICAL TRANSCRIPTION PROVIDE SOURCE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

5.       GLOBAL FINANCE & ACCOUNTS PROVIDE SOURCE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

6.       GLOBAL HEALTHCARE BPO  MARKET BY PAYER SERVICE 2015-2024 ($ MILLION)

7.       GLOBAL INTEGRATED FRONT-END SERVICES AND BACK-OFFICE OPERATIONS PAYER SERVICE MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

8.       GLOBAL  CLAIMS MANAGEMENT SERVICES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

9.       GLOBAL MEMBER MANAGEMENT SERVICES PAYER SERVICE  BY GEOGRAPHY 2015-2024 ($ MILLION)

10.   GLOBAL HEALTHCARE BPO BY PROVIDER MANAGEMENT SERVICES PAYERS SERVICE BY GEOGRAPHY 2015-2024 ($ MILLION)

11.   GLOBAL BILLING AND ACCOUNTS MANAGEMENT PAYER SERVICE  BY GEOGRAPHY 2015-2024 ($ MILLION)

12.   GLOBAL ANALYTICS AND FRAUD MANAGEMENT SERVICES PAYER SERVICE BY GEOGRAPHY 2015-2024 ($ MILLION)

13.   GLOBAL HEALTHCARE BPO  MARKET BY HR SERVICES MARKET 2015-2024 ($ MILLION)

14.   GLOBAL HEALTHCARE BPO MARKET BY PHARMACEUTICAL SERVICE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

15.   GLOBAL HEALTHCARE BPO  MARKET HEALTHCARE BPO MARKET BY PHARMACEUTICAL SERVICE MARKET 2015-2024 ($ MILLION)

16.   GLOBAL RESEARCH & DEVELOPMENT MARKET PHARMACEUTICAL SERVICE MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

17.   GLOBAL MANUFACTURING PHARMACEUTICAL SERVICE  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

18.   GLOBAL BY NON-CLINICAL SERVICES PHARMACEUTICAL SERVICE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

19.   GLOBAL OTHER NON-CLINICAL FUNCTIONS   MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

20.   NORTH AMERICA HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

21.   EUROPE HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

22.   ASIA PACIFIC HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

23.   REST OF THE WORLD HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

24.   NORTH AMERICA HEALTHCARE BPO  MARKET BY PROVIDE SOURCE 2015-2024 ($ MILLION)

25.   EUROPE HEALTHCARE BPO  MARKET BY PROVIDE SOURCE 2015-2024 ($ MILLION)

26.   ASIA PACIFIC HEALTHCARE BPO  MARKET BY PROVIDE SOURCE 2015-2024 ($ MILLION)

27.   REST OF THE WORLD HEALTHCARE BPO MARKET BY PROVIDE SOURCE 2015-2024 ($ MILLION)

28.   NORTH AMERICA HEALTHCARE BPO   MARKET BY PAYER SERVICE 2015-2024 ($ MILLION)

29.   EUROPE HEALTHCARE BPO  MARKET BY PAYER SERVICE 2015-2024 ($ MILLION)

30.   ASIA PACIFIC HEALTHCARE BPO   MARKET BY PAYER SERVICE 2015-2024 ($ MILLION)

31.   REST OF THE WORLD HEALTHCARE BPO   MARKET BY PAYER SERVICE 2015-2024 ($ MILLION)

32.   NORTH AMERICA HEALTHCARE BPO  MARKET BY HR SERVICES MARKET 2015-2024 ($ MILLION)

33.   EUROPE HEALTHCARE BPO  MARKET BY HR SERVICES MARKET  2015-2024 ($ MILLION)

34.   ASIA PACIFIC HEALTHCARE BPO  MARKET BY HR SERVICES MARKET 2015-2024 ($ MILLION)

35.   REST OF THE WORLD HEALTHCARE BPO  MARKET BY HR SERVICES MARKET 2015-2024 ($ MILLION)

36.   NORTH AMERICA HEALTHCARE BPO  MARKET BY PROVIDE SOURCE 2015-2024 ($ MILLION)

37.   EUROPE HEALTHCARE BPO  MARKET BY PAYER SERVICE  2015-2024 ($ MILLION)

38.   ASIA PACIFIC HEALTHCARE BPO  MARKET BY PHARMACEUTICAL 2015-2024 ($ MILLION)

39.   REST OF THE WORLD HEALTHCARE BPO  MARKET BY PHARMACEUTICAL 2015-2024 ($ MILLION)

40.   UNITED STATES HEALTHCARE BPO   MARKET BY APPLICATION 2015-2024 ($ MILLION)

41.   UNITED STATES HEALTHCARE BPO   MARKET BY PAYER SERVICE 2015-2024 ($ MILLION)

42.   UNITED STATES HEALTHCARE BPO   MARKET BY HR SERVICES MARKET 2015-2024 ($ MILLION)

43.   UNITED STATES HEALTHCARE BPO   MARKET BY PHARMACEUTICAL MARKET 2015-2024 ($ MILLION)

44.    

45.   CANADA STATES HEALTHCARE BPO   MARKET BY APPLICATION 2015-2024 ($ MILLION)

46.   CANDA HEALTHCARE BPO   MARKET BY PAYER SERVICE 2015-2024 ($ MILLION)

47.   CANADA HEALTHCARE BPO   MARKET BY HR SERVICES MARKET 2015-2024 ($ MILLION)

48.   CANADA HEALTHCARE BPO   MARKET BY PHARMACEUTICAL MARKET 2015-2024 ($ MILLION)

49.   UK STATES HEALTHCARE BPO   MARKET BY APPLICATION 2015-2024 ($ MILLION)

50.   UK HEALTHCARE BPO   MARKET BY PAYER SERVICE 2015-2024 ($ MILLION)

LIST OF FIGURES

1.       GLOBAL HEALTHCARE BPO  MARKET BY PROVIDE SOURCE  2015-2024 ($ MILLION)

2.       GLOBAL MEDICAL BILLING MARKET PROVIDE SOURCE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL MEDICAL CODING PROVIDE SOURCE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

4.       GLOBAL MEDICAL TRANSCRIPTION PROVIDE SOURCE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

5.       GLOBAL FINANCE & ACCOUNTS PROVIDE SOURCE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

6.       GLOBAL HEALTHCARE BPO  MARKET BY PAYER SERVICE 2015-2024 ($ MILLION)

7.       GLOBAL INTEGRATED FRONT-END SERVICES AND BACK-OFFICE OPERATIONS PAYER SERVICE MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

8.       GLOBAL  CLAIMS MANAGEMENT SERVICES MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

9.       GLOBAL MEMBER MANAGEMENT SERVICES PAYER SERVICE  BY GEOGRAPHY 2015-2024 ($ MILLION)

10.   GLOBAL HEALTHCARE BPO BY PROVIDER MANAGEMENT SERVICES PAYERS SERVICE BY GEOGRAPHY 2015-2024 ($ MILLION)

11.   GLOBAL BILLING AND ACCOUNTS MANAGEMENT PAYER SERVICE  BY GEOGRAPHY 2015-2024 ($ MILLION)

12.   GLOBAL ANALYTICS AND FRAUD MANAGEMENT SERVICES PAYER SERVICE BY GEOGRAPHY 2015-2024 ($ MILLION)

13.   GLOBAL HEALTHCARE BPO  MARKET BY HR SERVICES MARKET 2015-2024 ($ MILLION)

14.   GLOBAL HEALTHCARE BPO MARKET BY PHARMACEUTICAL SERVICE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

15.   GLOBAL HEALTHCARE BPO  MARKET HEALTHCARE BPO MARKET BY PHARMACEUTICAL SERVICE MARKET 2015-2024 ($ MILLION)

16.   GLOBAL RESEARCH & DEVELOPMENT MARKET PHARMACEUTICAL SERVICE MARKET  BY GEOGRAPHY 2015-2024 ($ MILLION)

17.   GLOBAL MANUFACTURING PHARMACEUTICAL SERVICE  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

18.   GLOBAL BY NON-CLINICAL SERVICES PHARMACEUTICAL SERVICE MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

19.   GLOBAL OTHER NON-CLINICAL FUNCTIONS   MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

20.   UNITED STATES (U.S.) HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

21.   CANADA HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

22.   UNITED KINGDOM (UK) HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

23.   FRANCE HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

24.   GERMANY HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

25.   SPAIN HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

26.   ROE HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

27.   CHINA HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

28.   INDIA HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

29.   JAPAN HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

30.   AUSTRALIA HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

31.   ROAPAC HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

32.   LATIN AMERICA HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION)

33.   MENA HEALTHCARE BPO  MARKET 2015-2024 ($ MILLION) 

 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.